Celldex Therapeutics, Inc.
CLDX
$20.50
-$0.32-1.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -7.17% | -4.06% | -5.77% | -2.61% | 94.49% |
| Total Receivables | 52.00% | -17.84% | -44.46% | -42.57% | 1.64% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -8.39% | -3.70% | 170.69% | -7.76% | 61.09% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -7.15% | -4.07% | -4.08% | -2.80% | 93.50% |
|
|
|||||
| Total Current Assets | -7.15% | -4.07% | -4.08% | -2.80% | 93.50% |
| Net Property, Plant & Equipment | -1.56% | 11.41% | 17.20% | 1.41% | -6.19% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.79% | 0.00% | 9,009.35% | 0.00% | 0.00% |
| Total Assets | -6.67% | -3.75% | -2.65% | -2.68% | 86.60% |
|
|
|||||
| Total Accounts Payable | 4.44% | 193.09% | -70.70% | 17.56% | -7.44% |
| Total Accrued Expenses | -24.78% | 19.99% | 51.68% | 6.03% | -20.40% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.24% | 5.29% | -13.22% | -3.35% | 1.86% |
| Total Finance Division Other Current Liabilities | 75.48% | -32.52% | -61.99% | -5.26% | -2.78% |
| Total Other Current Liabilities | 75.48% | -32.52% | -61.99% | -5.26% | -2.78% |
| Total Current Liabilities | -18.94% | 23.08% | 16.04% | 5.20% | -15.53% |
|
|
|||||
| Total Current Liabilities | -18.94% | 23.08% | 16.04% | 5.20% | -15.53% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -18.30% | 38.23% | 114.57% | 69.36% | -49.35% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -26.78% | 0.00% | 0.00% | 0.00% | -21.12% |
| Total Liabilities | -19.51% | 21.63% | 16.75% | 5.60% | -17.07% |
|
|
|||||
| Common Stock & APIC | 0.41% | 0.44% | 0.48% | 0.50% | 24.31% |
| Retained Earnings | -3.46% | -3.12% | -2.87% | -2.51% | -2.35% |
| Treasury Stock & Other | 7.66% | -37.33% | 197.08% | -20.68% | -32.16% |
| Total Common Equity | -5.89% | -4.95% | -3.41% | -2.98% | 95.40% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -5.89% | -4.95% | -3.41% | -2.98% | 95.40% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.89% | -4.95% | -3.41% | -2.98% | 95.40% |
|
|
|||||